|
India News Releases
|
(India.CityRegions.Com, May 06, 2016 ) Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars industry is getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and Biosimilars compliments to this goal.
Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar. It is very important to assess the variations in Biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for Biosimilars. Regulatory requirement for approving Biosimilars varies across different regulatory bodies.
However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of Biosimilars, extrapolation of indications, and interchangeability of Biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of Biosimilars in the market in the near future.
Other Key Points in Report:
The scope of the report includes - - Introduction - Market dynamics: Trends, Drivers, and Barriers - WHO guidance for Biosimilars - Regulatory overview, biosimilar guidelines, regulatory framework for Biosimilars, and market outlook for: Europe, USA, India, South Korea, Japan and China. - Key players - Pipeline Analysis - Overview - By Stage of Development / Molecule / Therapy Area / Indication - Late-Stage / Phase II / Phase I Pipeline Biosimilars
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001170002/buying
Reasons to Buy The report will enhance your decision-making capability by allowing you to - Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as Biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market - Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure - With the recent approvals of Biosimilars by USFDA, the Biosimilars market is going to grow and this report examines the post approval market landscape - Examine the Biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline - Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001170002/sample
Table of Content: An Overview
Executive Summary Introduction Biosimilars Industry Dynamics Trends Drivers Restraints Biosimilars Regulation: WHO's Guidance Biosimilars in Europe Overview Regulatory Framework Market Outlook Biosimilars in the US Overview Regulatory Framework Market Outlook Biosimilars in India Overview Regulatory Framework
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001170002/discount
Market Outlook Biosimilars in South Korea Overview Regulatory Framework Market Outlook Biosimilars in Japan Overview Regulatory Framework Market Outlook Biosimilars in China Overview Regulatory Framework Market Outlook Key Market Players Biosimilars Pipeline Analysis Overview By Stage of Development By Molecule By Therapy Area By Indication By MoA/RoA Late-Stage Pipeline Biosimilars Phase II Pipeline Biosimilars Phase I Pipeline Biosimilars
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001170002/buy/2995
About ReportsWeb: ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|